HomeACRV • NASDAQ
add
Acrivon Therapeutics Inc
Previous close
$1.58
Day range
$1.52 - $1.67
Year range
$1.05 - $4.42
Market cap
58.89M USD
Avg Volume
869.48K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 20.12M | -19.39% |
Net income | -18.98M | 16.85% |
Net profit margin | — | — |
Earnings per share | -0.49 | 9.26% |
EBITDA | -19.76M | 19.86% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 118.58M | -33.93% |
Total assets | 129.72M | -34.02% |
Total liabilities | 17.20M | -13.14% |
Total equity | 112.52M | — |
Shares outstanding | 38.74M | — |
Price to book | 0.44 | — |
Return on assets | -36.57% | — |
Return on capital | -40.75% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -18.98M | 16.85% |
Cash from operations | -15.24M | 12.23% |
Cash from investing | 21.52M | 49.35% |
Cash from financing | -192.00K | 70.32% |
Net change in cash | 6.10M | 269.54% |
Free cash flow | -9.31M | 12.60% |
About
Founded
2018
Headquarters
Website
Employees
74
